Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
International Journal of Surgical Pathology|January 17, 2009
RET/PTC rearrangement occurring in primary peritoneal carcinomaRichard Flavin, Gerhard Jackl, Stephen Finn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Vitamin D receptor protein expression in tumor tissue and prostate cancer progressionWhitney K Hendrickson, Richard Flavin, Julie L Kasperzyk, et al.Irish Journal of Medical Science|July 31, 2020
What GDPR and the Health Research Regulations (HRRs) mean for Ireland: "explicit consent"-a legal analysisMary Kirwan, Blanaid Mee, Niamh Clarke, et al.Irish Journal of Medical Science|July 31, 2020
What GDPR and the Health Research Regulations (HRRs) mean for Ireland: a research perspectiveBlanaid Mee, Mary Kirwan, Niamh Clarke, et al.Biopreservation and Biobanking|February 7, 2013
Maintaining Breast Cancer Specimen Integrity and Individual or Simultaneous Extraction of Quality DNA, RNA, and Proteins from Allprotect-Stabilized and Nonstabilized Tissue SamplesBlanaid C Mee, Paul Carroll, Simona Donatello, et al.Cancer Research|April 15, 2010
Immunohistochemical expression of BRCA1 and lethal prostate cancerMichelangelo Fiorentino, Gregory Judson, Kathryn Penney, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2017
Perineural Invasion and Risk of Lethal Prostate CancerPiotr Zareba, Richard Flavin, Masis Isikbay, et al.Stem Cells (Dayton, Ohio)|May 25, 2011
Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancerRoisin M Dwyer, James Ryan, Ronan J Havelin, et al.American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinomaRichard Flavin, Paul Smyth, Ciara Barrett, et al.Pageof 7